NOVARTIS AG

NVS

Delayed - 06/28 04:00:02 pm
84.17USD	-1.30%

NOVARTIS AG : Receives a Buy rating from Berenberg

05/27/2022 | 08:23am

Luisa Hector from Berenberg retains his positive opinion on the stock with a Buy rating. The target price remains unchanged at CHF 90.

05/27	FDA approves Novartis Kymriah(R) CAR-T cell therapy for adult patients with...
05/27	NOVARTIS AG : Receives a Buy rating from Berenberg
05/27	Novartis : Sandoz appoints new Board representative to global AMR Industry...
08/02	Novartis : Lp(a) HORIZON achieves 50% enrollment in trial to assess the...
05/2018	Novartis : DURECT Announces Amendment to Licensing Agreement with Sandoz...